Truxima User Reviews & Ratings
Truxima has an average rating of 7.8 out of 10 from a total of 4 reviews on Drugs.com. 75% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Non-Hodgkin's Lymphoma | 1 reviews for Non-Hodgkin's Lymphoma | 33 medications |
- She...
- Taken for 1 to 6 months
- May 25, 2023
"I was taking Rituxan for several years to suppress my immune system so my body would stop rejecting my lungs. I was switched to Truxima due to the cost of the hospital fee. Truxima does not work as well for me. Two doses four months apart, and I am having so much joint and body pain as well. I hope to go back to Rituxan."
- Goa...
- Taken for 5 to 10 years
- March 3, 2024
"First was on Rituxan. I got very sick while administered and severe head pain after. Truxima was able to control nausea during administration. It's a rough couple of weeks after with intestinal cramps & gas, fatigue, dizziness, and lethargy, but it does help the pain of RA, controls it in the lungs, and stops the fibromyalgia pain, which is a bonus since it's not used for that!"
Frequently asked questions
- What are biosimilar drugs and how do they compare to biologics?
- What is the difference between Truxima and Rituxan?
- Does Truxima make you gain weight?
- Is Truxima a chemotherapy drug?
- Dar...
- Taken for 1 to 6 months
- June 12, 2025
For Non-Hodgkin's Lymphoma "I am experiencing joint and bone pain. Also a sore neck. It did, however, knock down the effects of my Non-Hodgkin lymphoma, for which I am thankful. I am on maintenance infusions now, one time every 8 weeks."
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Monjuvi
Monjuvi is used for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or follicular ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat B-cell precursor acute lymphoblastic leukemia (ALL), large B-cell ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma (FL) in adults. It is a p ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Tazverik
Tazverik (tazemetostat) used for the treatment of patients with epithelioid sarcoma and follicular ...
Are you taking this medicine?
Your review helps others make informed decisions.More about Truxima (rituximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
- Truxima drug information
- Truxima (Rituximab Intravenous) (Advanced Reading)
- Truxima (Rituximab-abbs Intravenous) (Advanced Reading)
"First dose of Truxima in early May 2024, followed by a 2nd dose 2 weeks later for Dermatomyositis. After 10 weeks from my first dose, I started to feel relief. Muscle inflammation pain and stiffness receded, energy level increased, and mood improved. (No side effects) Started to feel symptoms creep back in early November, so 5 months of relief! Looking forward to my 2nd round of Truxima in early December. I am happy with the results after taking a number of drugs over the past 10 years. I am also on IVIG treatment on a monthly basis."